{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:13548"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:13548","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"The role of the tetraspanin6 (TSPAN6) in regulating the immune microenvironment in inflammatory breast cancer (IBC)","abstract":"Inflammatory breast cancer (IBC) is a rare and aggressive type of invasive breast cancer with poor outcomes. Previous studies demonstrated that IBC is characterised by an abundance of tumour-infiltrating immune cells. However, the mechanism(s) underlying the IBC-controlling accumulation of various immune cells remained unclear. By performing standard trans-well experiments under two time intervals (4-hour and 16-hour), we demonstrated that the medium conditioned by IBC cells (CM-IBC) was chemotactic for B lymphocytes. More importantly, we discovered that Tspan6, a poorly-studied tetraspanin, strengthened the chemoattractive potential of IBC for B cells. Through “immune cell depletion and supplementation” experiments, we uncovered the cellular pathways (i.e. monocyte-dependent, monocyte/CD8+ T lymphocyte-dependent and Pertussis Toxin (PTX)-sensitive pathways) by which Tspan6-expressing IBC cells enhanced the migration of B cells. With regard to the molecular pathway, we identified that syntenin-1, the only known partner protein of Tspan6, played a vital role in regulating the Tspan6-dependent migration of B cells. The disassociation of Tspan6 and syntenin-1 significantly attenuated the chemoattractive potential of IBC cells for B lymphocytes. In addition, the downstream effector, Src kinase and p38 MAPK, appeared to involve in the Tspan6-syntenin-1-dependent migration of B cells. In conclusion, we uncovered intracellular and extracellular pathways by which Tspan6-expressing IBC cells could enhance the migration of B cells. These findings may provide more insights into the complicated immune networks in IBC and provide novel targets for anti-tumour therapeutics.","abstract_html":"Inflammatory breast cancer (IBC) is a rare and aggressive type of invasive breast cancer with poor outcomes. Previous studies demonstrated that IBC is characterised by an abundance of tumour-infiltrating immune cells. However, the mechanism(s) underlying the IBC-controlling accumulation of various immune cells remained unclear. By performing standard trans-well experiments under two time intervals (4-hour and 16-hour), we demonstrated that the medium conditioned by IBC cells (CM-IBC) was chemotactic for B lymphocytes. More importantly, we discovered that Tspan6, a poorly-studied tetraspanin, strengthened the chemoattractive potential of IBC for B cells. Through “immune cell depletion and supplementation” experiments, we uncovered the cellular pathways (i.e. monocyte-dependent, monocyte/CD8+ T lymphocyte-dependent and Pertussis Toxin (PTX)-sensitive pathways) by which Tspan6-expressing IBC cells enhanced the migration of B cells. With regard to the molecular pathway, we identified that syntenin-1, the only known partner protein of Tspan6, played a vital role in regulating the Tspan6-dependent migration of B cells. The disassociation of Tspan6 and syntenin-1 significantly attenuated the chemoattractive potential of IBC cells for B lymphocytes. In addition, the downstream effector, Src kinase and p38 MAPK, appeared to involve in the Tspan6-syntenin-1-dependent migration of B cells. In conclusion, we uncovered intracellular and extracellular pathways by which Tspan6-expressing IBC cells could enhance the migration of B cells. These findings may provide more insights into the complicated immune networks in IBC and provide novel targets for anti-tumour therapeutics.","abstract_has_math":false,"creators":["Zhang, Jing"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-07","date_published":"2023-07","updated_at":"2026-11-19T09:32:19Z","subjects":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/13548/7/Zhang2023PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A13548","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Zhang, Jing"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-07-14"]},{"key":"dc:date.issued","label":"Date","values":["2023-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cancer and Genomic Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/13548/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/13548/7/Zhang2023PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Inflammatory breast cancer (IBC) is a rare and aggressive type of invasive breast cancer with poor outcomes. Previous studies demonstrated that IBC is characterised by an abundance of tumour-infiltrating immune cells. However, the mechanism(s) underlying the IBC-controlling accumulation of various immune cells remained unclear. By performing standard trans-well experiments under two time intervals (4-hour and 16-hour), we demonstrated that the medium conditioned by IBC cells (CM-IBC) was chemotactic for B lymphocytes. More importantly, we discovered that Tspan6, a poorly-studied tetraspanin, strengthened the chemoattractive potential of IBC for B cells. Through “immune cell depletion and supplementation” experiments, we uncovered the cellular pathways (i.e. monocyte-dependent, monocyte/CD8+ T lymphocyte-dependent and Pertussis Toxin (PTX)-sensitive pathways) by which Tspan6-expressing IBC cells enhanced the migration of B cells. With regard to the molecular pathway, we identified that syntenin-1, the only known partner protein of Tspan6, played a vital role in regulating the Tspan6-dependent migration of B cells. The disassociation of Tspan6 and syntenin-1 significantly attenuated the chemoattractive potential of IBC cells for B lymphocytes. In addition, the downstream effector, Src kinase and p38 MAPK, appeared to involve in the Tspan6-syntenin-1-dependent migration of B cells. In conclusion, we uncovered intracellular and extracellular pathways by which Tspan6-expressing IBC cells could enhance the migration of B cells. These findings may provide more insights into the complicated immune networks in IBC and provide novel targets for anti-tumour therapeutics."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["The role of the tetraspanin6 (TSPAN6) in regulating the immune microenvironment in inflammatory breast cancer (IBC)"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Zhang, Jing"],"dc:date":["2023-07-14"],"dc:date.issued":["2023-07"],"dc:description.abstract":["Inflammatory breast cancer (IBC) is a rare and aggressive type of invasive breast cancer with poor outcomes. Previous studies demonstrated that IBC is characterised by an abundance of tumour-infiltrating immune cells. However, the mechanism(s) underlying the IBC-controlling accumulation of various immune cells remained unclear. By performing standard trans-well experiments under two time intervals (4-hour and 16-hour), we demonstrated that the medium conditioned by IBC cells (CM-IBC) was chemotactic for B lymphocytes. More importantly, we discovered that Tspan6, a poorly-studied tetraspanin, strengthened the chemoattractive potential of IBC for B cells. Through “immune cell depletion and supplementation” experiments, we uncovered the cellular pathways (i.e. monocyte-dependent, monocyte/CD8+ T lymphocyte-dependent and Pertussis Toxin (PTX)-sensitive pathways) by which Tspan6-expressing IBC cells enhanced the migration of B cells. With regard to the molecular pathway, we identified that syntenin-1, the only known partner protein of Tspan6, played a vital role in regulating the Tspan6-dependent migration of B cells. The disassociation of Tspan6 and syntenin-1 significantly attenuated the chemoattractive potential of IBC cells for B lymphocytes. In addition, the downstream effector, Src kinase and p38 MAPK, appeared to involve in the Tspan6-syntenin-1-dependent migration of B cells. In conclusion, we uncovered intracellular and extracellular pathways by which Tspan6-expressing IBC cells could enhance the migration of B cells. These findings may provide more insights into the complicated immune networks in IBC and provide novel targets for anti-tumour therapeutics."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/13548/7/Zhang2023PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cancer and Genomic Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/13548/"],"dc:subject":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"dcterms:accessrights":["public"],"dc:title":["The role of the tetraspanin6 (TSPAN6) in regulating the immune microenvironment in inflammatory breast cancer (IBC)"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:32:19Z"}